Erik Harris

EVP & Chief Commercial Officer, Ultragenyx Pharmaceutical Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Mar 2, 2026

Companies

Ultragenyx Pharmaceutical Inc.EVP & Chief Commercial Officer −$0.2M

Trades

RARE Sold 10,539 shares at $22.80 $0.2M Mar 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.